Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1994-11-7
pubmed:abstractText
When cultivated on substrates that prevent cell adhesion (the polymer polyhydroxyethylmethacrylate, bovine serum albumin, and Teflon), human endothelial cells (EC) rapidly lost viability with a half-life of approximately 10 h. Dying EC showed the morphological and biochemical characteristics of apoptosis. The apoptotic process of suspended EC was delayed by the protein synthesis inhibitor cycloheximide. To obtain information as to the mechanism involved in the apoptosis of suspended EC, we investigated whether adhesion to matrix proteins or integrin occupancy in EC retaining a round shape may affect EC suicide. EC bound to low coating concentration of either fibronectin or vitronectin, retaining a round shape and failing to organize actin microfilaments, underwent to rapid cell death; by contrast, cells on high substrate concentrations became flattened, showed actin microfilament organization, and retained viability. Addition of saturating amounts of soluble vitronectin to suspended round-shaped EC did not reduce the process of apoptosis. Finally, when suspended EC bound Gly-Arg-Gly-Asp-Ser-coated microbeads (approximately 10 microbeads/cell), yet retaining a round shape, the apoptotic process was not affected. Oncogene-transformed EC in suspension were less susceptible to cell death and apoptosis than normal EC. Overall, these data indicate that cell attachment to matrix or integrin binding per se is not sufficient for maintaining cell viability, and that cells need to undergo some minimal degree of shape change to survive. Modulation of interaction with the extracellular matrix can, therefore, be an important target for the control of angiogenesis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-13293190, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-1382715, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-1526968, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-1555235, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-1652767, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-1688645, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-1717976, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-1726704, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-1852210, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-1931084, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-2326648, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-2333303, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-2428602, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-2450202, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-2453229, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-2455830, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-2458362, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-2460263, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-2467745, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-2469496, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-2946903, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-3021817, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-3045824, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-3058164, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-3680944, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-4561027, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-6157481, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-6245367, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-6254391, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-637870, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-6422024, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-661946, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-8106557, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-8257797, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-8332913, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-8387531, http://linkedlifedata.com/resource/pubmed/commentcorrection/7523422-903179
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0021-9525
pubmed:author
pubmed:issnType
Print
pubmed:volume
127
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
537-46
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells.
pubmed:affiliation
Istituto di Ricerche Farmacologiche Mario Negri, Centro Daniela e Catullo Borgomainerio, Milano, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't